Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial of VAL 083 in patients with non-small cell lung cancer

Trial Profile

A trial of VAL 083 in patients with non-small cell lung cancer

Status: Planning
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dianhydrogalactitol (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Del Mar Pharmaceuticals; Guangxi Wuzhou Pharmaceutical
  • Most Recent Events

    • 02 Sep 2015 According to a DelMar pharmaceuticals media release, details of this trial will be presented at the 16th World Conference on Lung Cancer.
    • 15 Jun 2015 This study will be covered in a presentation by DelMar Pharmaceuticals at The World NSCLC Summit, according to a company media release.
    • 09 Oct 2014 Following successful in vivo studies of VAL 083 in models of NSCLC, DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals are expecting to conduct a clinical trial of VAL 083 in patients in China, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top